Metastamirs: a stepping stone towards improved cancer management.

作者: Nicole M. A. White , Eman Fatoohi , Maged Metias , Klaus Jung , Carsten Stephan

DOI: 10.1038/NRCLINONC.2010.173

关键词:

摘要: MicroRNAs (miRNAs) are non-coding RNAs that regulate protein expression. Aberrant miRNA expression in cancer has been well documented; miRNAs can act as oncogenes or tumor-suppressor genes, depending on the cellular context and target genes they regulate, involved tumor progression metastasis. The potential mechanisms by which aggressiveness include migration, invasion, cell proliferation, epithelial-to-mesenchymal transition, angiogenesis apoptosis. MiRNAs various pathways an elicit more than one biological effect a given cell. Existing data show clinical utility of prognostic predictive markers for aggressive metastatic cancers. stability formalin-fixed, paraffin-embedded tissues body fluids is advantageous biomarker discovery validation. In addition, be extracted from small biopsy specimens, further advantage. Finally, therapeutic agents personalized management.

参考文章(138)
Sohail F. Tavazoie, Claudio Alarcón, Thordur Oskarsson, David Padua, Qiongqing Wang, Paula D. Bos, William L. Gerald, Joan Massagué, Endogenous human microRNAs that suppress breast cancer metastasis Nature. ,vol. 451, pp. 147- 152 ,(2008) , 10.1038/NATURE06487
Martin Spahn, Susanne Kneitz, Claus-Jürgen Scholz, Stenger Nico, Thomas Rüdiger, Philipp Ströbel, Hubertus Riedmiller, Burkhard Kneitz, Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. International Journal of Cancer. ,vol. 127, pp. 394- 403 ,(2009) , 10.1002/IJC.24715
Laura Poliseno, Andrea Tuccoli, Laura Mariani, Monica Evangelista, Lorenzo Citti, Keith Woods, Alberto Mercatanti, Scott Hammond, Giuseppe Rainaldi, MicroRNAs modulate the angiogenic properties of HUVECs. Blood. ,vol. 108, pp. 3068- 3071 ,(2006) , 10.1182/BLOOD-2006-01-012369
Dvora Nass, Shai Rosenwald, Eti Meiri, Shlomit Gilad, Hilla Tabibian-Keissar, Anat Schlosberg, Hagit Kuker, Netta Sion-Vardy, Ana Tobar, Oleg Kharenko, Einat Sitbon, Gila Lithwick Yanai, Eran Elyakim, Hila Cholakh, Hadas Gibori, Yael Spector, Zvi Bentwich, Iris Barshack, Nitzan Rosenfeld, MiR-92b and miR-9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors Brain Pathology. ,vol. 19, pp. 375- 383 ,(2009) , 10.1111/J.1750-3639.2008.00184.X
Takashi Sasayama, Masamitsu Nishihara, Takeshi Kondoh, Kohkichi Hosoda, Eiji Kohmura, MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. International Journal of Cancer. ,vol. 125, pp. 1407- 1413 ,(2009) , 10.1002/IJC.24522
Shuomin Zhu, Hailong Wu, Fangting Wu, Daotai Nie, Shijie Sheng, Yin-Yuan Mo, MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Research. ,vol. 18, pp. 350- 359 ,(2008) , 10.1038/CR.2008.24
Margaret S Ebert, Joel R Neilson, Phillip A Sharp, MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nature Methods. ,vol. 4, pp. 721- 726 ,(2007) , 10.1038/NMETH1079
Soeren Torge Mees, Wolf Arif Mardin, Sonja Sielker, Edith Willscher, Norbert Senninger, Christina Schleicher, Mario Colombo-Benkmann, Joerg Haier, Involvement of CD40 Targeting miR-224 and miR-486 on the Progression of Pancreatic Ductal Adenocarcinomas Annals of Surgical Oncology. ,vol. 16, pp. 2339- 2350 ,(2009) , 10.1245/S10434-009-0531-4
H Zhang, Y Li, M Lai, The microRNA network and tumor metastasis. Oncogene. ,vol. 29, pp. 937- 948 ,(2010) , 10.1038/ONC.2009.406